Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04047290 |
Title | A Study of AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors |
Recruitment | Unknown status |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Akesobio Australia Pty Ltd |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Border Medical Oncology | COMPLETED | Albury | New South Wales | Australia | Details | |
Scientia Clinical Research Ltd | RECRUITING | Randwick | New South Wales | Australia | Details | |
Blacktown Hospital | RECRUITING | Sydney | New South Wales | Australia | Details | |
ICON Cancer Foundation | RECRUITING | South Brisbane | Queensland | Australia | Details | |
Adelaide Cancer Centre | RECRUITING | Kurralta Park | South Australia | Australia | Details | |
Monash Health | RECRUITING | Clayton | Victoria | Australia | Details | |
Peter MacCallum Cancer Centre | RECRUITING | Melbourne | Victoria | Australia | Details |